Protokinetix, Inc. (PKTX) — 10-Q Filings

10-Q Filings (6)

• ProtoKinetix Deepens Losses Amidst Continued R&D Spending — Nov 13, 2025 Risk: high
  ProtoKinetix, Inc. (PKTX), a development stage medical research company, reported a net loss of $273,662 for the nine months ended September 30, 2025, an increa
• ProtoKinetix's Losses Mount Amidst Ongoing Research, Cash Infusion — Aug 13, 2025 Risk: high
  ProtoKinetix, Inc. (PKTX), a development stage company focused on medical research, reported a net loss of $188,757 for the six months ended June 30, 2025, an i
• ProtoKinetix Files Q1 2025 10-Q — May 15, 2025 Risk: low
  ProtoKinetix, Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as RJV Network Inc., is in the pharmaceutical preparations
• ProtoKinetix Files Q3 2024 10-Q — Nov 12, 2024 Risk: low
  ProtoKinetix, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly RJV Network Inc., is based in Dalton, OH, and operates in the
• ProtoKinetix, Inc. Files 10-Q for Q2 2024 — Jul 30, 2024 Risk: low
  ProtoKinetix, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly RJV Network Inc., is incorporated in Nevada and operates in the pha
• ProtoKinetix, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  ProtoKinetix, Inc. (PKTX) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. ProtoKinetix, Inc. filed a 10-Q report for the period ending March 31, 2

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX